EIKN — EIKON THERAPEUTICS INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 82 SEC-registered investment managers reported holding EIKN (EIKON THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $368.62M across 29.37M shares. That is +10.3% by share count (+2.57M shares) versus the previous quarter, while reported value moved +35.7%. Ownership is concentrated: the five largest holders account for 51.3% of reported value and the top ten for 71.1%.
Compared with the prior quarter, 39 opened new positions, 19 added to existing stakes, 10 trimmed, 14 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of EIKON THERAPEUTICS INC (EIKN) include Fidelity Management & Research (FMR), BlackRock Inc, Foresite Capital Management IV, LLC, ranked by reported 13F value among the 119 institutional holders on this page.
EIKN is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 63 | 19.81M | $158.67M | +17.4% |
| Q2 2026 | 82 | 29.37M | $368.62M | +10.3% |
| Q1 2026 | 57 | 26.35M | $268.52M | — |
| Q1 2025 | 3 | 2.85K | $34.05K | -96.0% |
| Q4 2024 | 3 | 71.20K | $799.08K | +225.7% |
| Q3 2024 | 3 | 21.86K | $439.29K | +15.6% |
| Q2 2024 | 3 | 18.91K | $617.00K | -69.9% |
| Q1 2024 | 3 | 62.87K | $610.46K | +169.2% |
Over the 8 quarters shown, institutional share counts increased 31403% in aggregate (Q1 2024 → Q3 2026); the largest single-quarter swing was Q4 2024 (+225.7%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 5.52M | $44.38M | 0.00% | Add | |
| 4.87M | $39.15M | 0.00% | Add | |
| 1.67M | $13.40M | 1.63% | Hold | |
| 1.18M | $9.45M | 0.00% | Hold | |
| 1.02M | $8.16M | 0.00% | Add | |
| 754.50K | $6.07M | 0.00% | Add | |
| 635.13K | $5.11M | 0.12% | New | |
| 608.84K | $4.90M | 0.00% | Add | |
| 484.67K | $3.90M | 2.14% | Hold | |
| 391.27K | $3.15M | 0.02% | New | |
| 298.00K | $2.40M | 0.11% | Add | |
| 278.90K | $2.24M | 0.00% | Add | |
| 350.00K | $2.24M | 0.00% | Hold | |
| 247.11K | $1.99M | 0.00% | Add | |
| 223.02K | $1.79M | 0.00% | Add | |
| 202.24K | $1.63M | 0.00% | Add | |
| 142.50K | $1.15M | 0.00% | Reduce | |
| 137.41K | $1.10M | 0.00% | Add | |
| 134.50K | $1.08M | 0.00% | Hold | |
| 71.25K | $572.89K | 0.00% | Add | |
| 65.87K | $529.60K | 0.00% | Add | |
| 63.83K | $513.19K | 0.00% | New | |
| 56.95K | $450.48K | 0.00% | Add | |
| 51.16K | $411.31K | 0.00% | Add | |
| 47.94K | $385.46K | 0.11% | New |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
Q1 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 3.84M | $40.59M | 0.00% | New | |
| 3.32M | $35.12M | 0.00% | New | |
| 1.94M | $20.56M | 8.67% | New | |
| 1.67M | $17.63M | 5.05% | New | |
| 1.32M | $13.95M | 5.15% | New | |
| 1.22M | $12.93M | 0.01% | New | |
| 1.14M | $12.10M | 0.00% | New | |
| 1.14M | $12.10M | 0.00% | New | |
| 1.02M | $10.81M | 0.00% | New | |
| 975.83K | $10.32M | 0.00% | New | |
| 969.43K | $10.26M | 0.00% | New | |
| 732.61K | $7.75M | 0.37% | New | |
| 555.55K | $5.88M | 0.04% | New | |
| 484.67K | $5.13M | 2.23% | New | |
| 395.34K | $4.18M | 2.02% | New | |
| 379.02K | $4.01M | 0.00% | New | |
| 350.00K | $3.70M | 0.00% | New | |
| 310.00K | $3.28M | 0.01% | New | |
| 305.23K | $3.23M | 1.76% | New | |
| 273.93K | $2.90M | 0.00% | New | |
| 265.00K | $2.80M | 0.01% | New | |
| 200.00K | $2.12M | 0.00% | New | |
| 185.00K | $1.96M | 0.00% | New | |
| 185.00K | $1.96M | 0.00% | New | |
| 175.63K | $1.86M | 0.00% | New |
Q1 2025 — 3 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 354 | $24.59K | 0.10% | Reduce | |
| 1.60K | $6.46K | 0.00% | Reduce | |
| 900 | $3.00K | 0.00% | Reduce |
Q4 2024 — 3 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.80K | $577.28K | 6.19% | Add | |
| 46.50K | $148.80K | 0.00% | Add | |
| 22.90K | $73.00K | 0.00% | Add |
Q3 2024 — 3 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.76K | $394.46K | 0.73% | Reduce | |
| 15.10K | $33.82K | 0.00% | Add | |
| 5.00K | $11.00K | 0.00% | Reduce |
New Positions (Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 556.96K sh · $7.27M
- Parkman Healthcare Partners LLC 256.05K sh · $3.34M
- Sixth Street Partners Management Company, L.P. 182.10K sh · $2.38M
- Schonfeld Strategic Advisors LLC 179.78K sh · $2.35M
- Affinity Asset Advisors, LLC 98.00K sh · $1.28M
- ALPS ADVISORS INC 54.95K sh · $717.07K
- Invesco Ltd 50.90K sh · $664.25K
- BNY Mellon 47.79K sh · $623.63K
- TCG Crossover Management, LLC 37.90K sh · $494.62K
- Polen Capital Management 35.74K sh · $466.43K
- ProShare Advisors LLC 29.68K sh · $387.39K
- Nuveen, LLC 28.99K sh · $378.29K
Fully Exited (vs previous quarter)
- JANE STREET GROUP, LLC sold 265.00K sh · $2.80M
- Wellington Management Group sold 185.00K sh · $1.96M
- WELLINGTON MANAGEMENT GROUP LLP sold 185.00K sh · $1.96M
- Blackstone Inc. sold 168.34K sh · $1.78M
- Goldman Sachs Group sold 129.31K sh · $1.37M
- LMR Partners LLP sold 115.00K sh · $1.22M
- SEVEN GRAND MANAGERS, LLC sold 80.00K sh · $846.40K
- Ghisallo Capital Management LLC sold 70.00K sh · $740.60K
- STATE STREET CORP sold 40.15K sh · $424.79K
- Squarepoint Ops LLC sold 30.98K sh · $327.75K
- AXQ CAPITAL, LP sold 15.41K sh · $163.02K
- Hudson Bay Capital Management LP sold 13.48K sh · $142.62K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Fidelity Management & Research (FMR) | 5.52M | 4.99M | 3.84M | — | — | — | — | — | — | — |
| BlackRock Inc | 4.87M | 4.28M | 3.32M | — | — | — | — | — | — | — |
| Merck & Co., Inc. | 1.67M | 1.67M | 1.67M | — | — | — | — | — | — | — |
| Capital World Investors | 1.18M | 1.18M | 1.14M | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.02M | 922.71K | 969.43K | — | — | — | — | — | — | — |
| Geode Capital Management | 754.50K | 556.96K | 273.93K | — | — | — | — | — | — | — |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 635.13K | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 608.84K | — | 40.15K | — | — | — | — | — | — | — |
| SOROS CAPITAL MANAGEMENT LLC | 484.67K | 484.67K | 484.67K | — | — | — | — | — | — | — |
| Walleye Capital LLC | 391.27K | — | — | — | — | — | — | — | — | — |
| Affinity Asset Advisors, LLC | 298.00K | 98.00K | — | — | — | — | — | — | — | — |
| UBS Group AG | 278.90K | 263.93K | 99.41K | — | — | — | — | — | — | — |
| Franklin Resources | 350.00K | 350.00K | 350.00K | — | — | — | — | — | — | — |
| Morgan Stanley | 247.11K | 12.03K | 15.27K | — | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 223.02K | 148.90K | 13.61K | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 202.24K | 148.41K | 131.95K | — | — | — | — | — | — | — |
| Ensign Peak Advisors, Inc | 142.50K | 170.49K | 200.00K | — | — | — | — | — | — | — |
| BNP PARIBAS FINANCIAL MARKETS | 137.41K | 8.51K | — | — | — | — | — | — | — | — |
| BNP Paribas Asset Management Holding S.A. | 134.50K | 134.50K | 140.34K | — | — | — | — | — | — | — |
| ALPS ADVISORS INC | 71.25K | 54.95K | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold EIKN?
As of 2026-Q2, 82 institutional funds reported holding EIKN (EIKON THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $368.62M.
How many shares of EIKN do institutions own?
13F filers reported 29.37M shares of EIKN, worth $368.62M in aggregate at the end of 2026-Q2.
Is institutional ownership of EIKN rising or falling?
Share counts moved +10.3% versus the prior quarter — accumulation.
Who are the top institutional holders of EIKN?
The largest 13F holders are Fidelity Management & Research (FMR), BlackRock Inc, Foresite Capital Management IV, LLC, T. Rowe Price Investment Management, Inc., Foresite Capital Management V, LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of EIKON THERAPEUTICS INC?
The major shareholders of EIKON THERAPEUTICS INC (EIKN) by reported 13F value are Fidelity Management & Research (FMR), BlackRock Inc, Foresite Capital Management IV, LLC, T. Rowe Price Investment Management, Inc., Foresite Capital Management V, LLC, among 119 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.